The Experience of Ibrutinib in Chronic Graft-Versus-Host Disease in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation: Single Center Experience-Reference-Cited by-同舟云学术

The Experience of Ibrutinib in Chronic Graft-Versus-Host Disease in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation: Single Center Experience

Published:2023-05-31 Issue:2 Volume:24 Page:216-220
ISSN:2619-9793
Container-title:Istanbul Medical Journal
language:
Short-container-title:Istanbul Med J

Author:

Sarıcı Ahmet^ORCID,Erkurt Mehmet Ali^ORCID,Kuku İrfan^ORCID,Kaya Emin^ORCID,Berber İlhami^ORCID,Biçim Soykan^ORCID,Hidayet Emine^ORCID,Kaya Ahmet^ORCID,Bahçecioğlu Ömer Faruk^ORCID,Tanrıverdi Lokman Hekim^ORCID,Özkan Sıdıka Gülkan^ORCID

Publisher

Galenos Yayinevi

Reference26 articles.

1. Early and Late Complications in Patients with Allogeneic Transplantation of Hematopoietic Stem Cell-Case Report;Trajkovska;Open Access Maced J Med Sci,2017

2. 2. Atilla PA, Atilla E, Toprak SK, Demirer T. Non-infectious early complications of allogeneic stem cell transplantations. UHOD 2016; 29: 239-50.

3. Transplantation-related mortality, graft failure, and survival after reduced-toxicity conditioning and allogeneic hematopoietic stem cell transplantation in 100 consecutive pediatric recipients;Satwani;Biol Blood Marrow Transplant,2013

4. 4. Atilla E, Atilla PA, Toprak SK, Demirer T. A review of late complications of allogeneic hematopoietic stem cell transplantations. Clinical transplantation 2017; 31: e13062.

5. Long-term survival and late deaths after allogeneic hematopoietic cell transplantation;Wingard;J Clin Oncol,2011

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ibrutinib;Reactions Weekly;2023-09-23